DMF domestic administrator duties in Japan

DMF domestic administrator duties in Japan
Product Description

Registration and management of DMFs for active pharmaceutical ingredients in Japan, and support services for exports to Japan

SPERA NEXUS, Inc

  • Country/Region:
    Japan
  • Founded:
    2020
  • On CPHI since:
    2024
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
CMO/CDMO
Distributor/Import Export
Manufacturer/Innovator
Primary activities
API Producer
Chemical Development
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Generic APIs producer
Intermediates Manufacturer

SPERA NEXUS, Inc

  • Country/Region:
    Japan
  • Founded:
    2020
  • On CPHI since:
    2024
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
CMO/CDMO
Distributor/Import Export
Manufacturer/Innovator
Primary activities
API Producer
Chemical Development
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Generic APIs producer
Intermediates Manufacturer

More Products from SPERA NEXUS, Inc (4)

  • Pilocarpine hydrochloride

    Product Pilocarpine hydrochloride

    Pilocarpine Hydrochloride is supplied in compliance with the USP and JP specification,  and is intended for use as an API in ophthalmic and xerostomia-related pharmaceutical products.It has already been used by many overseas manufacturers.
  • Trichlormethiazide

    Product Trichlormethiazide

    Trichlormethiazide is supplied in compliance with the JP and is used as an API for antihypertensive and diuretic pharmaceutical products.
  • Betahistine Mesilate

    Product Betahistine Mesilate

    Betahistine Mesilate is supplied in compliance with the JP and EP specification and is used as an API for anti-vertigo and vestibular disorder pharmaceutical products.
  • Phenylephrine hydrochloride

    Product Phenylephrine hydrochloride

    Phenylephrine Hydrochloride is supplied in compliance with the EP, USP and JP specification and is intended for use as an API in ophthalmic, nasal decongestant, and cardiovascular pharmaceutical products.